Filing Details
- Accession Number:
- 0001415889-22-011459
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-16 19:51:07
- Reporting Period:
- 2022-11-15
- Accepted Time:
- 2022-11-16 19:51:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1159036 | Halozyme Therapeutics Inc. | HALO | Biological Products, (No Disgnostic Substances) (2836) | 880488686 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1910662 | Nicole Labrosse | C/O Halozyme Therapeutics, Inc. 11388 Sorrento Valley Road San Diego CA 92121 | Svp, Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-11-15 | 4,635 | $53.82 | 4,410 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-11-15 | 365 | $53.69 | 4,045 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |